Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 197 Breast Neoplasms 112 Neoplasms 83 Fatigue 29 Prostatic Neoplasms 27 Lung Neoplasms 20 Colorectal Neoplasms 20 Obesity 19 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 11 Colonic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Rectal Neoplasms 10 Pancreatic Neoplasms 10 Lymphedema 10 Multiple Myeloma 9 Lymphoma 9 Hematologic Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Head and Neck Neoplasms 8 Weight Loss 7 Stomach Neoplasms 7 Cardiotoxicity 7 Peripheral Nervous System Diseases 6 Leukemia 6 Insulin Resistance 6 Esophageal Neoplasms 6 Brain Neoplasms 6 Sarcopenia 5 Endometrial Neoplasms 5

Interventions

Radiotherapy 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Cyclosporine 7 Cyclophosphamide 7 Busulfan 7 Whole-Body Irradiation 6 Melphalan 6 Radiofrequency Ablation 5 Mycophenolic Acid 5 Filgrastim 5 Antilymphocyte Serum 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Methotrexate 4 Etoposide 4 Drug Therapy 4 Cisplatin 4 fludarabine 3 Radiosurgery 3 Injections 3 Hepatectomy 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 lenvatinib 2 Vinblastine 2 Videotape Recording 2 Thiotepa 2 Standard of Care 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Exercise × Clear all

NCT05019989 2021-08-25

DIANA-5

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Completed

Breast Neoplasms, Motor Activity, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡